| Product Code: ETC8566249 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 New Zealand Opioid Receptor Agonist Market Overview |
3.1 New Zealand Country Macro Economic Indicators |
3.2 New Zealand Opioid Receptor Agonist Market Revenues & Volume, 2021 & 2031F |
3.3 New Zealand Opioid Receptor Agonist Market - Industry Life Cycle |
3.4 New Zealand Opioid Receptor Agonist Market - Porter's Five Forces |
3.5 New Zealand Opioid Receptor Agonist Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.6 New Zealand Opioid Receptor Agonist Market Revenues & Volume Share, By Receptor Binding, 2021 & 2031F |
3.7 New Zealand Opioid Receptor Agonist Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 New Zealand Opioid Receptor Agonist Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 New Zealand Opioid Receptor Agonist Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 New Zealand Opioid Receptor Agonist Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 New Zealand Opioid Receptor Agonist Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic pain conditions in New Zealand |
4.2.2 Rising awareness about the benefits of opioid receptor agonists in pain management |
4.2.3 Growing geriatric population in the country |
4.3 Market Restraints |
4.3.1 Stringent regulations and guidelines surrounding opioid prescriptions and usage |
4.3.2 Concerns about opioid addiction and abuse in New Zealand |
5 New Zealand Opioid Receptor Agonist Market Trends |
6 New Zealand Opioid Receptor Agonist Market, By Types |
6.1 New Zealand Opioid Receptor Agonist Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 New Zealand Opioid Receptor Agonist Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 New Zealand Opioid Receptor Agonist Market Revenues & Volume, By Fentanyl, 2021- 2031F |
6.1.4 New Zealand Opioid Receptor Agonist Market Revenues & Volume, By Codeine, 2021- 2031F |
6.1.5 New Zealand Opioid Receptor Agonist Market Revenues & Volume, By Morphine, 2021- 2031F |
6.1.6 New Zealand Opioid Receptor Agonist Market Revenues & Volume, By Buprenorphine, 2021- 2031F |
6.1.7 New Zealand Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.2 New Zealand Opioid Receptor Agonist Market, By Receptor Binding |
6.2.1 Overview and Analysis |
6.2.2 New Zealand Opioid Receptor Agonist Market Revenues & Volume, By Full Agonist, 2021- 2031F |
6.2.3 New Zealand Opioid Receptor Agonist Market Revenues & Volume, By Partial Agonist, 2021- 2031F |
6.3 New Zealand Opioid Receptor Agonist Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 New Zealand Opioid Receptor Agonist Market Revenues & Volume, By Pain management, 2021- 2031F |
6.3.3 New Zealand Opioid Receptor Agonist Market Revenues & Volume, By Cough Suppression, 2021- 2031F |
6.3.4 New Zealand Opioid Receptor Agonist Market Revenues & Volume, By Diarrhoea suppression, 2021- 2031F |
6.3.5 New Zealand Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.4 New Zealand Opioid Receptor Agonist Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 New Zealand Opioid Receptor Agonist Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.4.3 New Zealand Opioid Receptor Agonist Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4.4 New Zealand Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.5 New Zealand Opioid Receptor Agonist Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 New Zealand Opioid Receptor Agonist Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 New Zealand Opioid Receptor Agonist Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 New Zealand Opioid Receptor Agonist Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.5 New Zealand Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.6 New Zealand Opioid Receptor Agonist Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 New Zealand Opioid Receptor Agonist Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 New Zealand Opioid Receptor Agonist Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.4 New Zealand Opioid Receptor Agonist Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 New Zealand Opioid Receptor Agonist Market Import-Export Trade Statistics |
7.1 New Zealand Opioid Receptor Agonist Market Export to Major Countries |
7.2 New Zealand Opioid Receptor Agonist Market Imports from Major Countries |
8 New Zealand Opioid Receptor Agonist Market Key Performance Indicators |
8.1 Prescription rates of opioid receptor agonists in New Zealand |
8.2 Number of healthcare providers trained in prescribing opioid receptor agonists |
8.3 Patient satisfaction and reported pain relief levels with opioid receptor agonist treatment |
9 New Zealand Opioid Receptor Agonist Market - Opportunity Assessment |
9.1 New Zealand Opioid Receptor Agonist Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.2 New Zealand Opioid Receptor Agonist Market Opportunity Assessment, By Receptor Binding, 2021 & 2031F |
9.3 New Zealand Opioid Receptor Agonist Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 New Zealand Opioid Receptor Agonist Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 New Zealand Opioid Receptor Agonist Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 New Zealand Opioid Receptor Agonist Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 New Zealand Opioid Receptor Agonist Market - Competitive Landscape |
10.1 New Zealand Opioid Receptor Agonist Market Revenue Share, By Companies, 2024 |
10.2 New Zealand Opioid Receptor Agonist Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here